Price Chart: Evolus, Inc. (EOLS)

The visual representation of Evolus, Inc. (EOLS) quotes on GURU.Markets helps assess the expansion of the Jeuveau brand in Europe and profit growth driven by the youth segment. Evolus, Inc. (EOLS) is diversifying its portfolio with innovative injectables, successfully competing in premium cosmetology. High physician loyalty and FDA approval have created a powerful ecosystem, where the current indicator stands at 6.89, ensuring a rapid influx of new patients.

Price Chart: Evolus, Inc. (EOLS) for 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Evolus Inc (EOLS)

- stock quotes and analyst forecast:

Stock Price Evolus, Inc.|EOLS - Average Forecast Price

- company stock exchange capitalization indicators:

Market Value Evolus Inc|EOLS - Total Enterprise Value

- balance sheet equity data:

Net Assets per Single Share Evolus|EOLS - Company Book Value|Market Value to Book Value Ratio evolus.com|EOLS - Company Total Asset Base

- debt level and financial liquidity data:

- company profitability and valuation multiples indicators:

EOLS - Profit After Payment of Taxes|Expected Profit Evolus, Inc.|EOLS - Price to Earnings Ratio|Forward P/E Multiple Evolus|EOLS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Evolus Inc|EOLS - Operating profit before amortization|Net earnings per share for the last 12 months Evolus|EOLS - Earnings per share for the last four quarters|Quarterly EPS earnings growth evolus.com|EOLS - Earnings per share growth rate in current year|Expected earnings per share growth for next year Evolus, Inc.

- issuer revenue and sales details:

EOLS - Company Revenue|Company Projected Revenue Evolus, Inc.|EOLS - Price to Sales|Price-to-Projected Revenue Ratio Evolus Inc

Fundamental valuation:Evolus, Inc.

Price reflects the market equilibrium between supply and demand, transforming the business's operational efficiency into the value of a single share relative to Wall Street models. For Evolus, Inc. (EOLS), steady demand for injectables driven by customer loyalty establishes the valuation floor, allowing real-time quotes to identify periods of unjustified discounts or market overheating of the asset.

Competitors of Evolus, Inc. (EOLS)